Advantages of robot-assisted training in rehabilitation therapy to boost
The “Medical Robotics Market by Product, Application and Geography – Forecast and Analysis 2022-2026” report has been added to Technavio’s offering
Hikma expands into Canada with acquisition of Teligent sterile injectable assets
Post Views: 231 Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces that it has agreed to acquire the Canadian assets of Teligent Inc. (Teligent) for $45.75 million. The transaction is expected to be completed before the end of the first quarter of 2022. The acquisition marks Hikma’s expansion into Canada and includes a…
Heart Lung Machine Market to Gain Valuation of US$ 0.7 Bn by 2031, Notes TMR
Post Views: 204 The global heart lung machine market is estimated to expand at a CAGR of 6.9% during the forecast period from 2021 to 2031, according to analysts at Transparency Market Research (TMR). Hectic lifestyles, unhealthy eating habits, and disrupted sleep cycle among people from all across the globe are several important factors increasing…
Kerna Health Signs Deal with Total Brain; Will Integrate Total Brain Platform into Existing Behavioral Health Technologies
Post Views: 212 Total Brain, a mental health and brain performance monitoring and support platform, today announced that the company has signed a deal with Kerna Health, a leader in digital connected care. As part of the newly minted agreement, Kerna will integrate the Total Brain digital neurotech platform into the company’s Behavioral Health Integration…
Medical Device Contract Research Organization Market Size Worth $12.1 Billion By 2028: Grand View Research, Inc.
Post Views: 223 The global medical device contract research organization market size is expected to reach USD 12.1 billion by 2028, registering a CAGR of 8.6% from 2021 to 2028, according to a new report by Grand View Research, Inc. During the second half of the COVID-19 pandemic in 2020, the market witnessed a surge…
Global Nutraceuticals Market Report 2021-2026 with Profiles of Abbott Laboratories, Ajinomoto, BASF, Cargill, Nestle, Omega Protein Corp, Pharma Marine, Zymes
Post Views: 232 The global nutraceutical market should grow from $289.8 billion in 2021 to $438.9 billion by 2026, at a compound annual growth rate (CAGR) of 8.7% for the period of 2021-2026. The functional beverages as a product of the nutraceutical market should grow from $104.3 billion in 2021 to $162.4 billion by 2026,…
EUROPEAN COMMISSION APPROVES LUMYKRAS® (SOTORASIB) FOR PATIENTS WITH KRAS G12C-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER
Post Views: 258 Amgen (NASDAQ: AMGN) today announced that the European Commission (EC) has granted conditional marketing authorization for LUMYKRAS® (sotorasib), a first-in-class KRASG12C inhibitor, for the treatment of adults with advanced non-small cell lung cancer (NSCLC) with KRAS G12C mutation and who have progressed after at least one prior line of systemic therapy. Continued…
IDEAYA Biosciences Announces Acquisition of Proprietary INQUIRE™ Chemical Library to Enhance Synthetic Lethality Drug Discovery Platform
Post Views: 207 IDEAYA Biosciences, Inc. (Nasdaq:IDYA), a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, reported the acquisition of its INQUIRE™ Chemical Library to enhance the company’s synthetic lethality drug discovery platform. IDEAYA’s INQUIRE Chemical Library is a proprietary, expert-curated small-molecule library of over 200,000 chemical…
Oramed Subsidiary Oravax Medical Signs Cooperation and Purchase Agreement for an Initial Pre-Purchase of 10 Million Doses of Oral COVID-19 Vaccines with Tan Thanh Holdings to Commercialize in Southeast Asia
Post Views: 169 Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today announced that its subsidiary, Oravax Medical, has signed a Cooperation and Purchase Agreement with Vietnam-based Tan Thanh Holdings Investment Joint Stock Company to pre-purchase Oravax’s oral COVID-19 vaccine, currently in…
Partner announces First Patient Procedure with Hexvix in China under Special Access Program
Post Views: 182 Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner and exclusive distributor, Asieris MediTech in mainland China and Taiwan has communicated the first patient experience with Hexvix® in the Bo’ao Lecheng International Medical Tourism Pilot Zone in Hainan Province. Asieris communicated that Hexvix received its first prescription in China…
